Colgate-Palmolive Shares Plummet 2.23% as Earnings Woes and Strategic Shift Drive 299th-Highest Trading Volume

. 22, 2025, . The decline followed a mixed earnings report showing improved North American sales but weaker international performance, alongside a strategic shift toward higher-margin oral care products. Analysts noted the stock’s underperformance relative to the S&P 500, .

Recent market commentary highlighted Colgate’s ongoing cost-cutting initiatives, including the consolidation of manufacturing facilities and reduced marketing expenditures. While these measures boosted short-term margins, they raised concerns about long-term brand equity erosion. Institutional investors appeared to take profit, . The company’s decision to delay its dividend increase until 2026 also drew criticism from income-focused investors.

this scenario requires clarifying several parameters. For the stock universe, should we include all NYSE, NASDAQ, and AMEX-listed equities (including delisted names)? For liquidity ranking, would dollar volume (Close × Shares Traded) be preferred over raw share volume? Once the top 500 stocks are selected, should they be equally weighted or value-weighted? Finally, should transaction costs like commissions and slippage be factored in? If no preferences are specified, standard defaults will be applied: NYSE/NASDAQ/AMEX universe, dollar volume ranking, equal weighting, and no trading costs. Please confirm or adjust these assumptions before proceeding.